Adrenocortical carcinoma epidemiology and demographics: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
{{Adrenocortical carcinoma}} | {{Adrenocortical carcinoma}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{RT}} | ||
==Overview== | ==Overview== | ||
Adrenocortical carcinoma is a rare tumor, with incidence of 1-2 per million population annually.<ref name="DeVita">{{cite book |author=edited by Vincent T. DeVita, Samuel Hellman, Steven A. Rosenberg |title=Cancer: principles & practice of oncology |publisher=Lippincott-Raven |location=Philadelphia |year=2005 |pages=|isbn=0-7817-4865-8 |oclc= |doi=}}</ref><ref name="UTDACC">{{cite web | last =Savarese | first =Diane MF | coauthors =Lynnette K Nieman| title =Clinical presentation and evaluation of adrenocortical tumors| work =UpToDate Online v. 15.1| publisher =UpToDate| date = August 8, 2006| url =http://www.uptodateonline.com/utd/content/topic.do?topicKey=adrenal/17707&type=A&selectedTitle=1~16 | accessdate =June 5, 2007}}</ref>Adrenocortical carcinoma has a bimodal distribution by age, with cases clustering in children under 6, and in adults 30-40 years old.<ref name="DeVita"/> | Adrenocortical carcinoma is a rare tumor, with incidence of 1-2 per million population annually.<ref name="DeVita">{{cite book |author=edited by Vincent T. DeVita, Samuel Hellman, Steven A. Rosenberg |title=Cancer: principles & practice of oncology |publisher=Lippincott-Raven |location=Philadelphia |year=2005 |pages=|isbn=0-7817-4865-8 |oclc= |doi=}}</ref><ref name="UTDACC">{{cite web | last =Savarese | first =Diane MF | coauthors =Lynnette K Nieman| title =Clinical presentation and evaluation of adrenocortical tumors| work =UpToDate Online v. 15.1| publisher =UpToDate| date = August 8, 2006| url =http://www.uptodateonline.com/utd/content/topic.do?topicKey=adrenal/17707&type=A&selectedTitle=1~16 | accessdate =June 5, 2007}}</ref> Adrenocortical carcinoma has a bimodal distribution by age, with cases clustering in children under 6, and in adults 30-40 years old.<ref name="DeVita"/> | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 08:31, 29 July 2012
|
Adrenocortical carcinoma Microchapters |
|
Differentiating Adrenocortical carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Study |
|
Adrenocortical carcinoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Adrenocortical carcinoma epidemiology and demographics |
|
FDA on Adrenocortical carcinoma epidemiology and demographics |
|
CDC on Adrenocortical carcinoma epidemiology and demographics |
|
Adrenocortical carcinoma epidemiology and demographics in the news |
|
Blogs on Adrenocortical carcinoma epidemiology and demographics |
|
Risk calculators and risk factors for Adrenocortical carcinoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]
Overview
Adrenocortical carcinoma is a rare tumor, with incidence of 1-2 per million population annually.[1][2] Adrenocortical carcinoma has a bimodal distribution by age, with cases clustering in children under 6, and in adults 30-40 years old.[1]
References
- ↑ 1.0 1.1 edited by Vincent T. DeVita, Samuel Hellman, Steven A. Rosenberg (2005). Cancer: principles & practice of oncology. Philadelphia: Lippincott-Raven. ISBN 0-7817-4865-8.
- ↑ Savarese, Diane MF (August 8, 2006). "Clinical presentation and evaluation of adrenocortical tumors". UpToDate Online v. 15.1. UpToDate. Retrieved June 5, 2007. Unknown parameter
|coauthors=ignored (help)